What Makes Semaglutide Different Uses a single hormone pathway (GLP-1) to support appetite control Often a great option for patients who prefer a more gradual approach Well-studied with a long track record in metabolic care What Makes Tirzepatide Different Activates two hormone pathways (GLP-1 and GIP) for broader metabolic support May provide stronger appetite suppression for some patients Often considered for patients who need additional metabolic support or have experienced plateaus What Clinical Trials Show GLP-1s Can Do The Proof in the Data Semaglutide By week 68, 86.4% lost at least 5%, 69.1% lost at least 10%, and 50.5% lost at least 15%
Tendon and Ligament Models BPC-157 has been investigated in connective tissue research models examining fibroblast migration, cytoskeletal signaling, and extracellular matrix organization during tendon repair
In animal research, BPC-157 has shown a favorable tolerability profile at studied doses
inspect for discolouration or particles (note that B12 solution is normally red) Prepare the injection site common sites include the thigh (vastus lateralis) for both IM and SC injections, or the ventrogluteal area for IM administration if trained to use this site Administration technique: Clean the injection site with an alcohol wipe and allow to dry completely
Drawing 27 units instead of 25 units means you are taking 2.7mg instead of 2.5mg
